Reg. no. 5565321071 · Manufacture of basic pharmaceutical products and pharmaceutical preparations · RYDAHOLM
Rh-Invest AB is registered with the legal form Limited company, is based in RYDAHOLM and is active in Manufacture of basic pharmaceutical products and pharmaceutical preparations. Revenue for 2025 was 26.7 MSEK.
Fiscal year ending 2025-08-31 · Amounts in SEK
Net revenue
26.7 MSEK
▲ +87%Operating result
5.2 MSEK
▼ −73%Net result
3.2 MSEK
▼ −73%Employees (annual report)
1
Total assets
87.8 MSEK
Equity
75.5 MSEK
Equity ratio
85.9 %
Profit margin
12 %
MSEK
Rh-Invest AB increased net sales by 87.6 % to 26.7 MSEK in 2025. Rh-Invest AB reported an operating margin of 19.6 % in 2025, down from 135.1 %. The company has reported a positive net result every year since 2023. Net sales per employee came to roughly 26.7 MSEK for 2025.
Calculated by ArkivNord from filed annual reports. Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Per the signatures in the annual report for the fiscal year ending 2025-08-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
Rh-Invest AB's reg. no. is 5565321071.
Rh-Invest AB reported revenue of 26.7 MSEK for the fiscal year 2025.
Yes — Rh-Invest AB reported a net profit of 3.2 MSEK for 2025.
Rh-Invest AB had 1 employees as of the most recently reported period (2025).
Rh-Invest AB is registered under Manufacture of basic pharmaceutical products and pharmaceutical preparations.
Rh-Invest AB is based in RYDAHOLM.
arkivnord